Equillium Inc to Discuss EQUATE Study in aGVHD at EHA Virtual Congress Transcript
Welcome and thank you for joining us this morning for Equillium's presentation of their top-line data from the EQUATE study in first-line acute graft-versus-host disease.
With me this afternoon to discuss data from the EQUATE study are Mr. Bruce Steel, Chief Executive Officer; Dr. Stephen Connelly, Chief Scientific Officer; and Dr. Dolca Thomas, Chief Medical Officer.
Before we begin, I would like to remind you that any statements made during this call that are not historical are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these statements as a result of various important factors. This includes those discussed in the Risk Factors section in the Company's most recent annual report on Form 10-K as well as other reports filed with the SEC.
I'll remind you that this call is being recorded and a replay of this call will be available on the Company's Web site following the conclusion of the call. And with that, I'm pleased to turn the call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
